Dr. Shayna Sarosiek, MD, MS is an Assistant Professor of Medicine in Hematology and Medical Oncology for the Boston University School of Medicine. Dr. Sarosiek completed her fellowship in Hematology & Oncology and Amyloidosis at Boston Medical Center, in which she was Chief Fellow in Hematology & Oncology. Dr. Sarosiek, also completed her residency and internship at Boston Medical Center. She received her MD from the University of Miami School of Medicine, her MS in Biomedicine from Barry University and her BA from Wake Forest University.
- Member, Amyloidosis Center, Boston University
- University of Miami School of Medicine, MD
- GMS MM 707
- MED MS 220
- Published on 5/27/2020
Dennis M, Maoz A, Cirstea D, Patel A, Lerner A, Sarosiek S. Treatment disparities in minority groups with multiple myeloma at a safety-net hospital. Leuk Lymphoma. 2020 May 27; 1-4. PMID: 32460648.
- Published on 4/30/2020
Sanchorawala V, Sarosiek S, Schulman A, Mistark M, Migre ME, Cruz R, Sloan JM, Brauneis D, Shelton AC. Safety, tolerability, and response rates of daratumumab in relapsed AL amyloidosis: results of a phase 2 study. Blood. 2020 Apr 30; 135(18):1541-1547. PMID: 31978210.
- Published on 4/1/2020
White PS, Dennis M, Jones EA, Weinberg JM, Sarosiek S. Risk Factors for Development of Hypocalcemia in Patients With Cancer Treated With Bone-Modifying Agents. J Natl Compr Canc Netw. 2020 04; 18(4):420-427. PMID: 32259788.
- Published on 3/10/2020
Staron A, Burks EJ, Lee JC, Sarosiek S, Sloan JM, Sanchorawala V. Assessment of minimal residual disease using multiparametric flow cytometry in patients with AL amyloidosis. Blood Adv. 2020 Mar 10; 4(5):880-884. PMID: 32130406.
- Published on 3/9/2020
Angel-Korman A, Stern L, Angel Y, Sarosiek S, Menn-Josephy H, Francis J, Ghai S, Sloan JM, Sanchorawala V, Havasi A. The Role of Kidney Transplantation in Monoclonal Ig Deposition Disease. Kidney Int Rep. 2020 Apr; 5(4):485-493. PMID: 32274452.
- Published on 10/23/2019
Sarosiek S, Sanchorawala V. Treatment Options For Relapsed/refractory Systemic Light-Chain (AL) Amyloidosis: Current Perspectives. J Blood Med. 2019; 10:373-380. PMID: 31695543.
- Published on 10/4/2019
Gupta VK, White PS, Brauneis D, Shelton AC, Quillen K, Sanchorawala V, Sarosiek S, Sloan JM. Safety of autologous stem cell transplantation in patients with known Human T-cell Lymphotropic Viruses Type 1 and 2 infection: A case series of four patients. Am J Hematol. 2019 12; 94(12):E317-E319. PMID: 31489689.
- Published on 9/4/2019
Batalini F, Aleixo GF, Maoz A, Sarosiek S. Haemodialysis-associated thrombocytopenia: interactions among the immune system, membranes and sterilisation methods. BMJ Case Rep. 2019 Sep 04; 12(9). PMID: 31488440.
- Published on 8/2/2019
Pudusseri A, Sanchorawala V, Sloan JM, Bever KM, Doros G, Kataria S, Sarosiek S. Prevalence and prognostic value of D-dimer elevation in patients with AL amyloidosis. Am J Hematol. 2019 10; 94(10):1098-1103. PMID: 31292986.
- Published on 1/21/2019
Phull P, Sanchorawala V, Brauneis D, Sloan JM, Siddiqi OK, Quillen K, Sarosiek S. High-dose melphalan and autologous peripheral blood stem cell transplantation in patients with AL amyloidosis and cardiac defibrillators. Bone Marrow Transplant. 2019 08; 54(8):1304-1309. PMID: 30664726.
View 23 more publications: View full profile at BUMC